Ridker Paul M. and MacFadyen Jean G. and Thuren Tom and Everett Brendan M. and Libby Peter and Glynn Robert J. and CANTOS Trial Group and Forster Tamás and Ridker Paul and Lorenzatti Alberto and Krum Henry and Varigos John and Siostrzonek Peter and Sinnaeve Peter and Fonseca Francisco and et al.:
Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
LANCET, 390 (10105).
pp. 1833-1842.
ISSN 0140-6736
(2017)
Creators: |
Ridker Paul M. | MacFadyen Jean G. | Thuren Tom | Everett Brendan M. | Libby Peter | Glynn Robert J. | CANTOS Trial Group | Forster Tamás (kollab) MTMT | Ridker Paul (kollab) | Lorenzatti Alberto (kollab) | Krum Henry (kollab) | Varigos John (kollab) | Siostrzonek Peter (kollab) | Sinnaeve Peter (kollab) | Fonseca Francisco (kollab) | et al. (kollab) |
|
Item Type: |
Journal Article
|
Szerzők száma: |
113 |
Journal or Publication Title: |
LANCET |
Date: |
2017 |
Volume: |
390 |
Number: |
10105 |
Page Range: |
pp. 1833-1842 |
ISSN: |
0140-6736 |
Faculty/Unit: |
Faculty of Medicine |
Institution: |
University of Szeged (2000-) |
Language: |
English |
MTMT rekordazonosító: |
31270601 |
DOI azonosító: |
https://doi.org/10.1016/S0140-6736(17)32247-X |
Date Deposited: |
2022. Apr. 12. 14:02 |
Last Modified: |
2022. Aug. 11. 11:07 |
URI: |
http://publicatio.bibl.u-szeged.hu/id/eprint/24062 |
Actions (login required)
 |
View Item |